Basket

  Untick selected:   0
  1. Údaje podporujú Keytrudu firmy Merck pre prvú líniu liečby NSCLC = Data back Merck's Keytruda for first-line NSCLC / Peter Beržinec. Onkológia Roč. 11, č. 3 (2016), s. 190
    article

    article


  This site uses cookies to make them easier to browse. Learn more about how we use cookies.